Compare PED & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PED | NTRB |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.2M | 57.0M |
| IPO Year | N/A | N/A |
| Metric | PED | NTRB |
|---|---|---|
| Price | $0.58 | $4.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 117.4K | 63.5K |
| Earning Date | 11-17-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 156.43 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $33,244,999.00 | $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | $305.89 | $3,394.36 |
| P/E Ratio | $5.52 | ★ N/A |
| Revenue Growth | N/A | ★ 12.69 |
| 52 Week Low | $0.43 | $4.17 |
| 52 Week High | $0.94 | $11.78 |
| Indicator | PED | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 59.17 | 49.58 |
| Support Level | $0.53 | $4.25 |
| Resistance Level | $0.59 | $4.85 |
| Average True Range (ATR) | 0.03 | 0.25 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 85.91 | 63.24 |
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.